Konferenzen  >  Medizin & Gesundheitswesen  >  Onkologie  >  Virtuelle Veranstaltung

The European Association for Cancer Research

This highly interactive online meeting for early-career researchers focuses on career development. It will cover all the topics that our ECR members tell us they need – such as leadership skills, personal growth, translating research, and bridging the gap between academia and industry – and will offer plenty of opportunities for delegates to speak directly with the experts. The target audience for this conference is: scientists in the early phase of their career who want to develop a career in cancer research. The programme is tailored for scientists in the process of starting their independent path, as well as for researchers engaging with the clinical and industrial applications of their work.

Conference Officer: Hannah Barrs;     Tel.: [N/A];     Email: hannah.barrs@eacr.org

cancer research, cancer research careers, oncology, oncology careers, career guidance, leadership skills, cancer research leadership, personal development, translating research, working in academia, working in industry, science sustainability, grant writing, science creativity, science diversity, personal brands, translational cancer research, basic cancer research, preclinical cancer research

The European Association for Cancer Research (EACR)

This conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients. The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development. Join us online on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 29 July and register before 09 September to secure your place.

Conference Officer: Hannah Barrs;     Tel.: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, therapeutic targets, cancer drug discovery, drug discovery approaches, new technical approaches to cancer therapeutics, early clinical development, small molecule technology, phenotypic screens, covalent fragment screens, degrader technology, PROTAC, molecular glue, peptide technology, oral cyclic peptide inhibitors, antibody technology, antitumour approaches, antibody drug conjugates, targeting RAS, targeting mutant p53.